Publications by authors named "Robbert Van Manen"

Claim this Profile
A
Artificial intelligence in pharmacovigilance signal management: a review of tools, implementations, research, and regulatory landscape.
Maria Antonietta Barbieri, Vera Battini, Carla Carnovale, Marianna Cocco, Despoina Georgia Papoutsi, Robbert P Van Manen

Expert Opin Drug Saf· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the potential relationship between antineoplastic agents and their association with stomatitis and oral candidiasis in cancer patients.
Ali Amanati, Robbert Van Manen, Laleh Mahmoudi, Hafez Shojaadini, Seyed Reza Abdipour Mehrian

J Oncol Pharm Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antineoplastic agents associated with neutropenic enterocolitis in patients with malignancy: A quantitative safety signal analysis.
Ali Amanati, Robbert Van Manen, Sarvin Sajedianfard, Hafez Shojaadini, Mohadese Boroughani

J Oncol Pharm Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase.
Vera Battini, Robbert P Van Manen, Michele Gringeri, Giulia Mosini, Greta Guarnieri

Front Pharmacol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signaling COVID-19 Vaccine Adverse Events.
Rave Harpaz, William DuMouchel, Robbert Van Manen, Alexander Nip, Steve Bright

Drug Saf· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database.
Faizan Mazhar, Vera Battini, Michele Gringeri, Marco Pozzi, Giulia Mosini, Robbert P van Manen

Expert Opin Biol Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of the Food and Drug Administration Adverse Event Reporting System for Tramadol-Related Hypoglycemia.
Katherine M Juba, Robbert P van Manen, Shawn E Fellows

Ann Pharmacother· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signal detection for bleeding associated with the use of direct oral anticoagulants.
Kobi T Nathan, Kelly M Conn, Robbert P van Manen, Jack E Brown

Am J Health Syst Pharm· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dipeptidyl Peptidase-4 Inhibitor-Associated Pancreatic Carcinoma: A Review of the FAERS Database.
Angela K Nagel, Nabila Ahmed-Sarwar, Paul M Werner, Gabriela C Cipriano, Robbert P Van Manen

Ann Pharmacother· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How safe are recently FDA-approved antimicrobials? A review of the FDA adverse event reporting system database.
Tina M Khadem, Robbert P van Manen, Jack Brown

Pharmacotherapy· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tigecycline-related pancreatitis: a review of spontaneous adverse event reports.
Emmanuel Okon, Christian Engell, Robbert van Manen, Jack Brown

Pharmacotherapy· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential for linezolid-related blindness: a review of spontaneous adverse event reports.
Jack Brown, Samuel L Aitken, Robbert P van Manen

Pharmacotherapy· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signal detection methodologies to support effective safety management.
Robbert P van Manen, David Fram, William DuMouchel

Expert Opin Drug Saf· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis